CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, InVivo’s Chief Executive Officer, is scheduled to make a presentation at the Sidoti Semi-Annual New York Micro-Cap Conference at 8:00-8:35 AM EDT on Thursday, June 14, 2012, in the Estate 4 Carnegie Hall room. The Company's executives will also meet with financial community members to discuss the Company's ongoing operations. The conference will be held at the Grand Hyatt New York Hotel in midtown Manhattan.
